Showing results (21-30 of 149) with videos related to
Sort By:
Pageof 15
Targeted Oncology|March 9, 2012
Targeting pattern recognition receptors in cancer immunotherapyNadège Goutagny, Yann Estornes, Uzma Hasan, et al.Trends in Immunology|September 14, 2010
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancerIvan Hirsch, Christophe Caux, Uzma Hasan, et al.Journal for Immunotherapy of Cancer|March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.Cancers|August 2, 2019
Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional AnalysesMargaux Hubert, Elisa Gobbini, Nathalie Bendriss-Vermare, et al.Trends in Immunology|January 22, 2002
Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cellsGiampiero Girolomoni, Christophe Caux, Serge Lebecque, et al.European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Neoepitopes-based vaccines: challenges and perspectivesVincent Alcazer, Paola Bonaventura, Laurie Tonon, et al.Targeted Oncology|February 14, 2012
Targeting regulatory T cellsChristine Ménétrier-Caux, Tyler Curiel, Julien Faget, et al.Trends in Cancer|July 19, 2017
Emerging Role of the Unfolded Protein Response in Tumor ImmunosurveillanceHélène Vanacker, Jessica Vetters, Lyvia Moudombi, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected]Christelle de Brito, Martine Tomkowiak, Raffaella Ghittoni, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell developmentAndrea M Woltman, Catherine Massacrier, Johan W de Fijter, et al.Pageof 15